Skip to main content
. 2019 Nov 12;9:16574. doi: 10.1038/s41598-019-53242-x

Figure 1.

Figure 1

Short-chain fatty acid (SCFA) supplementation exerts metabolic benefits. Body weight changes (A), liver and white adipose tissue (WAT) weights (B), blood glucose (C), plasma insulin (D), glucose tolerance test (GTT) (E), insulin tolerance test (ITT) (F), GLP-1 (G), and PYY levels (H) measured after 4 weeks of normal chow (NC) or high-fat diet (HFD) feeding supplemented with 5% SCFAs. All data are presented as the means ± SEM (n = 8–12). Dunnett’s test; ***P < 0.001, **P < 0.01, and *P < 0.05, compared with HFD. ###P < 0.001, ##P < 0.01, and #P < 0.05 (HFD vs. NC), ***P < 0.001 and *P < 0.05 (HFD vs. Ace), †††P < 0.001 and P < 0.05 (HFD vs. Pro), §§§P < 0.001 and §P < 0.05 (HFD vs. But) (A,E,F). Epi: epididymal tissue, Peri: perirenal tissue, Sub: subcutaneous tissue.